Danaher raises full-year adjusted EPS guidance to $8.45-$8.60 and projects 3%-4% core revenue growth for 2026.
Danaher updated its 2026 financial outlook, raising adjusted earnings per share guidance to a range of $8.45-$8.60. The company also forecasted 3%-4% core revenue growth for the year following the early closure of its Masimo acquisition.
Second-quarter results exceeded expectations, with strong performance in Life Sciences driving better-than-anticipated revenue, earnings, and cash flow. CEO Rainer Blair highlighted the segment’s strongest quarter in several years, attributing the outperformance to operational execution and the accelerated Masimo integration.
The revised guidance reflects confidence in sustained momentum across Danaher’s portfolio, particularly in high-growth areas. No immediate market reaction was disclosed in the earnings call summary.